Form 4: Hims & Hers Officer Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc. officer Irene Becklund sold 8,411 shares of Class A Common Stock for $36.71 per share, as part of a pre-arranged trading plan.

Summary

• Irene Becklund, an officer (PAO) of Hims & Hers Health, Inc. (HIMS), reported a transaction involving the company's Class A Common Stock.
• On December 17, 2025, Becklund disposed of 8,411 shares of Class A Common Stock.
• The shares were sold at a price of $36.71 per share.
• Following this transaction, Becklund beneficially owns 2,126 shares of Class A Common Stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on August 7, 2024.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-scheduled insider stock sale under a 10b5-1 plan, which is generally considered neutral in terms of market sentiment as it does not typically signal new information about the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing details a routine insider stock transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, pre-scheduled insider stock sale under a 10b5-1 plan, which is a common practice for corporate insiders to manage their equity holdings.

Key Dates

Recommendation

This Form 4 filing details a pre-scheduled insider stock sale by an officer under a Rule 10b5-1 trading plan. Such routine transactions typically do not reflect a change in the company's fundamental outlook or provide new material information that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Hims & Hers, HIMS, insider trading, Form 4, stock sale, Irene Becklund, 10b5-1 plan